Shogo Yamazaki

The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer

Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige et al. · Molecular Cancer · 2023 · 47 citations · Full text

Medicine, Cancer Biology, Oncology +17

Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab

Yusuke Yano, Takaya Ohno, Kazumasa Komura et al. · Cancers · 2022 · 19 citations · Full text

Medicine, Immunology, Oncology +17

Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab

Kazumasa Komura, Satoshi Tokushige, Mitsuaki Ishida et al. · Cancer Science · 2023 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma

Takuya Tsujino, Kazumasa Komura, Teruo Inamoto et al. · World Journal of Urology · 2023 · 12 citations

Medicine, Surgery, Urology +17

Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium

Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura et al. · International Journal of Clinical Oncology · 2024 · 10 citations

Medicine, Oncology, Urology +14